Literature DB >> 15882249

Clinical features of type 1 autoimmune hepatitis in elderly Italian patients.

A Granito1, L Muratori, G Pappas, P Muratori, S Ferri, F Cassani, M Lenzi, F B Bianchi.   

Abstract

BACKGROUND: The usual onset of type 1 autoimmune hepatitis occurs at puberty or around menopause, whereas disease presentation in the advanced age is less often reported. AIM: To assess the clinical, immunological and histological features of Type 1 autoimmune hepatitis in elderly Italian patients.
METHODS: We assessed, at diagnosis, the clinical and immunological features of 76 consecutive Italian patients with type 1 autoimmune hepatitis, focusing particularly on a subgroup of 20 patients presenting at > or = 65 years (females 95%, median age 72 years, range 65-82).
RESULTS: In comparison with the younger group, at the time of autoimmune hepatitis diagnosis, elderly Italian patients are more often asymptomatic (25% vs. 7%; P = 0.04), are more frequently positive for antinuclear autoantibodies (95% vs. 52%; P = 0.0004) and HLA-DR4 (45% vs. 18%; P = 0.03); among the extra-hepatic manifestations, autoimmune thyroid disorders are prevalent in the elderly group (25% vs. 5%; P = 0.02). However, no difference was observed in the histological/biochemical expression of the liver disease and response to immunosuppression.
CONCLUSIONS: In elderly Italian patients, autoimmune hepatitis has typical serological and genetic characteristics, is more frequently asymptomatic, although prognosis and response to therapy is similar to that of younger patients. As a concomitant autoimmune thyroid disorder is common, autoimmune hepatitis should be suspected and investigated in elderly patients with autoimmune thyroid disorder and abnormal liver function tests.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882249     DOI: 10.1111/j.1365-2036.2005.02488.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

Review 2.  Autoimmune hepatitis--approach to diagnosis.

Authors:  Albert J Czaja
Journal:  MedGenMed       Date:  2006-05-23

Review 3.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 4.  COVID-19 and Autoimmune Liver Diseases.

Authors:  Annarosa Floreani; Sara De Martin
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

5.  Management of patients with difficult autoimmune hepatitis.

Authors:  Richard Parker; Ye Htun Oo; David H Adams
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 6.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Clinical, serological, histopathological and treatment profile of autoimmune hepatitis in the elderly.

Authors:  Nikhil Sonthalia; Shubham Jain; Ravi Thanage; Parmeshwar Junare; Sanjay Chandnani; Vinay Pawar; Qais Contractor; Pravin Rathi
Journal:  Clin Exp Hepatol       Date:  2020-02-17

8.  Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.

Authors:  Mei Xue; Yi Shen; Xiaoli Fan; Mengyi Shen; Li Yang
Journal:  Can J Gastroenterol Hepatol       Date:  2021-01-04

9.  Autoimmune Hepatitis with Acute Presentation: Clinical, Biochemical, and Histological Features of 126 Patients.

Authors:  Álvaro Urzúa; Carolina Pizarro; Abraham Gajardo; Rafael Poniachik; Claudia Pavez; Máximo Cattaneo; Javier Brahm; Laura Carreño; Jaime Poniachik
Journal:  Can J Gastroenterol Hepatol       Date:  2022-09-26

10.  Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.

Authors:  Martine A M C Baven-Pronk; Maaike Biewenga; Joanne J van Silfhout; Aad P van den Berg; Henk R van Buuren; Bart J Verwer; Carin M J van Nieuwkerk; Gerd Bouma; Bart van Hoek
Journal:  Clin Transl Gastroenterol       Date:  2018-07-02       Impact factor: 4.488

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.